Brief: Dermtech Study Demonstrated DMT's Effectiveness As Melanoma Rule-Out Test For All Skin Types
Jan 18 (Reuters) - DermTech Inc DMTKW.PK :
* DERMTECH ANNOUNCES POSITIVE TOPLINE RESULTS FROM A STUDY
EVALUATING THE DERMTECH MELANOMA TEST (DMT) ACROSS ALL SKIN
TYPES
* DERMTECH INC: NEGATIVE PREDICTIVE VALUE (NPV) HIGHER THAN
99%
REGARDLESS OF SKIN TYPE
* DERMTECH INC: STUDY DEMONSTRATED DMT'S EFFECTIVENESS AS A
MELANOMA RULE-OUT TEST FOR ALL SKIN TYPES
Source text for Eikon: ID:nBw10XqlMa
Further company coverage: DMTKW.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DermTech
See all newsBrief: Dermtech Announces Completion Of Workforce Reduction And One-Time Charge To Be Incurred In Q2
DermTech shares sink after filing for bankruptcy
Brief: Dermtech Files For Voluntary Chapter 11 Protection
Brief: Dermtech Inc Files For Chapter 11 Bankruptcy- Court Filing
Brief: DermTech To Explore Strategic Alternatives, Implement Restructuring Plan